Cyclic GMP binding and phosphodiesterase: implication for platelet function.

P Hamet; J F Coquil; S Bousseau-Lafortune; D J Franks; J Tremblay

Home/Archive/PubMed

PubMed · 6202123

Cyclic GMP binding and phosphodiesterase: implication for platelet function.

P Hamet·J F Coquil·S Bousseau-Lafortune·D J Franks·J Tremblay

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

1-Methyl-3-isobutylxanthine 3',5'-Cyclic-AMP Phosphodiesterases 3',5'-Cyclic-GMP Phosphodiesterases Adenosine Diphosphate Blood Platelets Carrier Proteins Cyclic GMP Dipyridamole Humans Intracellular Signaling Peptides and Proteins Nitroprusside Platelet Aggregation Receptors, Cyclic AMP Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

P Hamet, J F Coquil, S Bousseau-Lafortune, D J Franks, J Tremblay. 1984. Cyclic GMP binding and phosphodiesterase: implication for platelet function.. https://pubmed.ncbi.nlm.nih.gov/6202123/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

Insulin-stimulated GLUT4 translocation is mediated by a divergent intracellular signaling pathway.

Insulin stimulates glucose transport largely by mediating translocation of the insulin-sensitive glucose transporter (GLUT4) from an intracellular compartment to the plasma membrane. Using single cell microinjection of 3T3-L1 adipocytes, coupled with immunofluorescence detection of GLUT4 proteins, we have determined that inhibition of endogenous p21ras or injection of oncogenic p21ras has no effect on insulin-stimulated GLUT4 translocation. On the other hand, microinjection of anti-phosphotyrosine antibodies or inhibition of endogenous phosphatidylinositol 3-kinase by microinjection of a GST-p85 SH2 fusion protein markedly inhibits this biologic effect of insulin. These data suggest that the p21ras/mitogen-activated protein kinase pathway is not involved in this metabolic effect of insulin, whereas tyrosine phosphorylation and stimulation of phosphatidylinositol 3-kinase activity are critical components of this signaling pathway.

1-Methyl-3-isobutylxanthine↗

PubMed1995

Calcineurin feedback inhibition of agonist-evoked cAMP formation.

The effects of immunosuppressant blockers of calcineurin (protein phosphatase 2B) on cAMP formation and hormone release were investigated in mouse pituitary tumor (AtT20) cells. Immunosuppressants enhanced corticotropin-releasing factor- and isoproterenol-evoked cAMP production in proportion with their potency to block calcineurin. Further analysis of cAMP production revealed that intracellular Ca2+ derived through voltage-regulated calcium channels reduces cAMP formation induced by corticotropin releasing-factor or beta 2-adrenergic stimulation and that this effect of Ca2+ is inhibited by blockers of calcineurin. AtT20 cells were found to express at least three species of adenylyl cyclase mRNA-encoding types 1 and 6 as well as a novel isotype, which appeared to be the predominant species. In two cell lines expressing very low or undetectable levels of the novel cyclase mRNA (NCB20 and HEK293 cells respectively), corticotropin-releasing factor-induced cAMP formation was not altered upon blockage of calcineurin activity. These data identify calcineurin as a Ca2+ sensor that mediates the negative feedback effect of intracellular Ca2+ on receptor-stimulated cAMP production. Furthermore, the effect of calcineurin on cAMP synthesis appears to be associated with the expression of a novel adenylyl cyclase isotype, which is highly abundant in AtT20 cells.

1-Methyl-3-isobutylxanthine↗

PubMed1995

Inhibition of glycosphingolipid synthesis induces p34cdc2 activation in Xenopus oocyte.

In Xenopus prophase-blocked oocytes, it is assumed that progesterone interacts with the plasma membrane to initiate a signalling cascade that ultimately leads to MPF activation. Progesterone regulates negatively the cAMP pathway through an inhibition of adenylate cyclase. However, the mechanisms linking the initial action of the hormone with adenylate cyclase activity remain to be elucidated. Here, we demonstrate that PDMP, an inhibitor of glucosphingolipid synthesis, triggers oocyte meiotic maturation in a cAMP- and cycloheximide-dependent manner, whereas exogenous ceramide is unefficient. We propose that sphingolipid metabolism and targeting represent an important regulatory process of oocyte meiosis.

1-Methyl-3-isobutylxanthine↗